健脾补肾方联合DP方案治疗术后非小细胞肺癌的临床探究.pdfVIP

健脾补肾方联合DP方案治疗术后非小细胞肺癌的临床探究.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
健脾补肾方联合DP方案治疗术后非小细胞肺癌的临床探究

提 要 目的:“气阴两虚”是肺癌发病的基本病机之一,本研究从益气养阴出发,观察 2 2 DP 方案(多西紫杉醇 75 mg/m ,d1 静脉滴注;顺铂 25-30mg/ m ,d1-d3 静脉滴注, 21 天为一个周期)化疗联合健脾补肾方治疗术后非小细胞肺癌患者的疗效。方法: 将临床确诊的 40 例非小细胞肺癌术后患者随机分成两组,其中观察组(化疗联合健 脾补肾方加减)20 例,对照组(单纯化疗)20 例,连续观察两个化疗疗程后,比较 两组治疗前后中医症候评分、生活质量卡氏评分、体重、肿瘤标志物、免疫功能变化 情况以及毒副反应的出现情况。结果:健脾补肾方配合化疗可较好的改善临床症状, 稳定并增加体重,提高生活质量,提高机体免疫功能,降低肿瘤标志物 CEA 和 CA125 的水平,减轻血液系统不良反应。结论:健脾补肾方配合化疗对术后非小细胞肺癌患 者有确切的治疗作用,值得进一步深入研究。 关键词 健脾补肾方;非小细胞肺癌;DP 方案;临床研究 Clinical Study on Postoperative Non-small Cell Lung Cancer Treated By “Jian pi bu shen fang”Combined With Chemotherapy Speciality: Internal Medicine of TCM Author: Zhou Qing Tutor: Professor Qi Yuanfu Abstract Objective:Deficiency of both vital energy and yin is one of the basic pathogenesis of lung cancer.Supplementing qi and nourishing yin is one of the most important principles of treatment. Based on it ,we choose“Jian pi bu shen fang”combined with chemotherapy (DP regimen) to study the curative effect of Chinese medicines and chemotherapy on postoperative non-small cell lung cancer.Methods:40 postoperative cases with non-small cell lung cancer were randomly divided into two groups.20 patients in the treated group were administered with “Jian pi bu shen fang” and chemotherapy (DP regimen),20 in the control group with chemotherapy alone.Objective effects and the changes of subjective symptoms were studied during both periods of treatment. Results:After two periods of treatment ,the subjective symptoms 、KPS 、weight 、the tumor marks(CEA+CA125) 、 immune parameters were significantly improved in the treated group ,better than in the control one.But there was no difference between two groups on the toxicity occurent rate and toxic degree were slighter in the trea

文档评论(0)

iludyapz + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档